<DOC>
	<DOCNO>NCT01977079</DOCNO>
	<brief_summary>Among patient hospitalize Threatened Premature Delivery ( TPD ) , rate premature birth ( PB ) 37 week 42 % , reflect inability accurately identify patient high risk PB . Currently , clinical biological marker recognize reliable predict real risk AP case MAP . The purpose study improve knowledge predictor preterm delivery compare conventional blood marker estimate serum procalcitonin accord premature delivery patient hospitalize preterm labor .</brief_summary>
	<brief_title>Procalcitonin Threatened Premature Delivery</brief_title>
	<detailed_description />
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Calcitonin</mesh_term>
	<criteria>age &gt; 18 year Ongoing pregnancy start date pregnancy know confirm ultrasound 1st Quarter perform 10 14 week measurement crownrump length hospitalization preterm labor 24 36 week gestation Intact membrane , oppose participate study Pregnancy uncertain term ( early ultrasound ) Pregnancy combine condition interfere assay perform , Uterine malformation know Multiple pregnancy , Premature rupture membrane , Chrorioamnionitis , Fetal malformation know Strapping GB &gt; 15000 CRP &gt; 10 mg / L , No affiliation social security scheme . Woman measure legal protection</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>pregnancy</keyword>
	<keyword>premature birth</keyword>
	<keyword>procalcitonin</keyword>
</DOC>